Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

Nature

Volumn 398, Issue 6722, 1999, Pages 77-80

  Sigal, Luis J ^a   Crotty, Shane ^b   Andino, Raul ^b   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; BONE MARROW CELLS; CHIMERA; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLIOVIRUS; RECEPTORS, VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS;

ANIMALIA;

EID: 0033522179     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/18038     Document Type: Article

References (29)

1. York, I. A. & Rock, K. L. Antigen precessing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14, 369-396 (1996).
2. Rock, K. L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17, 131-137 (1996).
3. Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71, 1205-1214 (1992).
4. Huang, A. Y., Bruce, A. T., Pardoll, D. M. & Levitsky, H. I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4, 349-355 (1996).
5. Restifo, N. P. et al. Antigen processing in viva and the elicitation of primary CIL responses. J. Immunol. 154, 4414-4422 (1995).
6. Rotzschke, O. et al. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21, 2891-2894 (1991).
7. Lee. M. S. et al. Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J. Virol. 66, 2617-7630 (1992).
8. Taylor, G., Stott, E. J., Wertz, G. & Ball, A. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+phenotypes of vaccinia virus recombinants after intranasal inoculation of mice. J. Gen. Virol. 72, 125-130 (1991).
9. Buller, R. M., Smith, G. L., Cremer, K., Notkins, A. L. & Moss, B. Decreased virulencen of recombinant vaccinia virus expresison vectors is associated with a thymidine kinase negative phenotype. Nature 317, 813-815 (1985).
10. Kundig, T. M. et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268, 1343-1347 (1995).
11. Zinkernagel, R. M., Kreeb, G. & Althage, A. Lymphohemopoietic origin of the immunogenic, virusantigen-presenting cells triggering anti-viral T-cell responses. Clin. Immunol. Immunopathol. 15, 565-576 (1980).
12. Bevan, M. I. Minor H antigens introduced on H-2 different stimulating cells crossreact at the cytotoxic T cell level during in vivo priming. J. Immunol. 117, 2233-2238 (1976).
13. Ren, R. B., Costantini, F., Gorgacz, E. J., Lee, J. J. & Racaniello, V. R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63, 353-362 (1990).
14. Mandl, S., Sigal, L. J., Rock, K. L. & Andino, R. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc. Natl Acad. Sci. USA 95, 8216-8221 (1998).
15. Ren, R. & Racaniello, V. R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66, 296-304 (1992).
16. Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288 (1976).
17. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. & Rock, K. L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl Acad. Sci. USA 90, 4942-4946 (1993).
18. Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. & Heath, W. R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186, 239-243 (1997).
19. Kurts, C. et al. Constitutive class 1-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930 (1996).
20. Reis e Sousa, C. & Germain, R. N. Major histocompatihility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182, 841-851 (1995).
21. Rock, K. L. & Clark, K. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol. 156, 3721-3726 (1996).
22. Albert, M. L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89 (1998).
23. Shen, Z., Reznikoff, G., Dranoff, G. & Rock, K. L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730 (1997).
24. Pfeifer, J. D. et al. Phagocytic processing of bacteriol antigens for class I MHC presentation to T cells. Nature 361, 359-362 (1993).
25. Bachmann, M. F. et al. TAP1-independent loading of class I molecules by exogenous viral proteins, Eur. J. Immunol. 25, 1739-1743 (1995).
26. Kovacsovics-Bankowski, M. & Rock, K. L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-253 (1995).
27. Ploegh, H. L. Viral strategies of immune evasion, Science 280, 248-253 (1998).
28. Sigal, L. J., Reiser, H. & Rock, K. L. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161, 2740-2745 (1998).
29. Moore, M. W., Carbone, F. R. & Bevan, M. J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785 (1988).